China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Lycium Barbarum Glycopeptide Intervention in Mild Cognitive Impairment: A Randomized Double-Blind Controlled Study'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136167
Registration Time: 2026/11/06
Type: Interventional study
Primary Sponsor: Shanghai Fourth People's Hospital, School of Medicine, Tongji University,
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327919
Published by HT Digital Content Services with permission from Health Daily Digest....